STOCK TITAN

YSX Tech (YSXT) adds independent audit committee financial expert to its board

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

YSX Tech. Co., Ltd reported that Mei Wang resigned as a director effective July 17, 2026, citing personal reasons and indicating no disagreement with the company’s operations, policies, or practices.

To fill the resulting vacancy, the board appointed Jifeng Wu, age 42, as a director effective the same date. The board determined that he is an independent director and an audit committee financial expert under SEC and Nasdaq standards. Wu joined the audit, compensation, and nominations committees. His background includes senior finance and accounting roles at Sunshine Life Insurance Co., Ltd. and Chang’an Liability Insurance Co., Ltd., as well as prior banking and biotechnology company experience. The company states there are no family relationships or appointment arrangements involving Wu.

Positive

  • None.

Negative

  • None.
independent director regulatory
"The Board has determined that Mr. Wu qualifies as an independent director"
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
audit committee financial expert regulatory
"The Board has also determined that Mr. Wu qualifies as an audit committee financial expert"
A person on a company’s board who has deep knowledge of accounting, financial reporting and auditing, able to understand and question the books, controls and audit work like a trained mechanic inspecting an engine. Investors care because that expertise helps spot errors, weaknesses or misleading statements early, improving the likelihood that financial reports are accurate and reducing the risk of surprises that can hurt a company’s value.
International Financial Reporting Standard 17 financial
"responsible for leading International Financial Reporting Standard 17 implementation"
National Financial Regulatory Administration regulatory
"managing National Financial Regulatory Administration regulatory reporting"
anti-money laundering regulatory
"responsible for corporate account review and custody, bank reconciliations, AML reviews"
Anti-money laundering are rules, checks and processes banks and other financial firms use to stop criminals from hiding or moving illegal money. Think of it like ID checks and receipts in a store that make it harder to pass off stolen goods as legitimate; for investors, strong anti-money laundering controls reduce the risk of fines, shutdowns, and reputational damage that can wipe out shareholder value.

FAQ

What board change did YSXT disclose in its August 2026 Form 6-K?

YSX Tech. Co., Ltd disclosed that Mei Wang resigned as a director effective July 17, 2026, and Jifeng Wu was appointed the same day, filling the vacancy on the company’s board.

Why did Mei Wang resign from the YSXT board?

Mei Wang resigned as a director of YSX Tech. Co., Ltd for personal reasons. The company states her departure was not due to any disagreement regarding its operations, policies, or practices.

What role will Jifeng Wu have on YSXT’s board committees?

Jifeng Wu was appointed to YSX Tech. Co., Ltd’s audit committee, compensation committee, and nominations committee, reflecting a central role in the company’s oversight and governance structure.

Is Jifeng Wu considered an independent director at YSXT?

Yes. The board of YSX Tech. Co., Ltd determined that Jifeng Wu qualifies as an independent director and as an audit committee financial expert or financially sophisticated under applicable rules.

What is the professional background of new YSXT director Jifeng Wu?

Jifeng Wu has held senior accounting and finance roles at Sunshine Life Insurance Co., Ltd. and Chang’an Liability Insurance Co., Ltd., and previously worked in banking and biotechnology, with experience in IFRS 17 and regulatory reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2026

 

Commission File Number: 001-42444

 

YSX TECH. CO., LTD

 

Room 102, Building 1, No. 22, Huazhou Road

Haizhu District, Guangzhou, Guangdong

People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F x Form 40-F ¨

 

 

 

 

 

Resignation of Directors

 

On July 17, 2026, Mei Wang (“Ms. Wang”) notified YSX TECH. CO., LTD (the “Company”) of her resignation as a director of the Company. Ms. Wang has advised that her resignation was due to personal reasons and not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company. Ms. Wang’s resignations became effective on July 17, 2026.

 

Appointment of Directors

 

To fill the vacancies created by the resignations of Ms. Wang, on July 17, 2026, the board of directors (the “Board”) of the Company appointed Jifeng Wu (“Mr. Wu”) to serve as a director of the Company, effective July 17, 2026.

 

The Board has determined that Mr. Wu qualifies as an independent director of the Company. Mr. Wu has been appointed to the audit committee, the compensation committee, and the nominations committee of the Board. The Board has also determined that Mr. Wu qualifies as an audit committee financial expert within the meaning of the SEC rules or possesses financial sophistication within the meaning of the Nasdaq corporate governance rules.

 

Mr. Wu, age 42, has served as Senior Supervisor of Business Accounting in the Finance Department at Sunshine Life Insurance Co., Ltd., an insurance company, since January 2018, where he is responsible for leading International Financial Reporting Standard 17 (“IFRS 17”) implementation, managing National Financial Regulatory Administration (“NFRA”) regulatory reporting, business accounting verification, system issue resolution, and financial system requirements. From May 2013 to January 2018, Mr. Wu served as Financial Accountant and Management Accountant in the Planning and Finance Department at Chang’an Liability Insurance Co., Ltd., an insurance company, where he was responsible for monthly business analysis, company-wide budget execution, daily accounting, investment and reinsurance accounting, and assisting in the development of accounting policies and expense control systems. From January 2012 to April 2013, Mr. Wu served as Assistant to the General Manager at Beijing Zhongke Paite Biotechnology Co., Ltd., a biotechnology company, where he assisted with policy implementation, meeting preparation, market research, and marketing initiative planning. From July 2010 to December 2011, Mr. Wu served as Account Manager in the Operations Management Department at China Minsheng Bank, Zhengzhou Branch, where he was responsible for corporate account review and custody, bank reconciliations, AML reviews, and large-amount transaction verification. From July 2008 to June 2010, Mr. Wu served as Universal Teller at Industrial Bank, Zhengzhou Branch, where he handled corporate and retail settlement, accounting records management, blank voucher custody, and regulatory system reporting. Mr. Wu received his Bachelor’s degree in Financial Engineering and Economics from Dongbei University in July 2008.

 

There is no family relationship between Mr. Wu and any director or executive officer of the Company. To the best knowledge of the Company, there is no understanding or arrangement between Mr. Wu and any other person pursuant to which she or he was appointed as a director.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  YSX TECH. CO., LTD
Date: August 13, 2026    
  By: /s/ Jie Xiao
  Name: Jie Xiao
  Title: Chief Executive Officer